To further validate the role of these metabolites in the antitumor effect, we conducted molecular docking studies to explore the interactions between differential metabolites in P. crataegi and core tumor targets such as SRC, GAPDH, and CASP3. The gene discussed is CASP3; the disease is neoplasm.